BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 31770617)

  • 1. Preventive tuberculosis treatment effect on QuantiFERON TB-Gold in-tube testing in a high tuberculosis-endemic country: A clinical trial.
    Yang Q; Ruan Q; Liu X; Shen Y; Jiang T; Wu J; Cai L; Pan K; Lin M; Huang X; Shao L; Zhang W
    Int J Infect Dis; 2020 Feb; 91():182-187. PubMed ID: 31770617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of isoniazid therapy for latent TB infection on QuantiFERON-TB gold in-tube responses in adults with positive tuberculin skin test results in a high TB incidence area: a controlled study.
    Johnson JL; Geldenhuys H; Thiel BA; Toefy A; Suliman S; Pienaar B; Chheng P; Scriba T; Boom WH; Hanekom W; Hatherill M
    Chest; 2014 Mar; 145(3):612-7. PubMed ID: 24135768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic changes of interferon gamma release assay results with latent tuberculosis infection treatment.
    Xin H; Cao X; Zhang H; Liu J; Pan S; Li X; Guan L; Shen F; Liu Z; Wang D; Guan X; Yan J; Li H; Feng B; Zhang M; Yang Q; Jin Q; Gao L;
    Clin Microbiol Infect; 2020 Nov; 26(11):1555.e1-1555.e7. PubMed ID: 32062048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and follow-up of treatment of latent tuberculosis; the utility of the QuantiFERON-TB Gold In-tube assay in outpatients from a tuberculosis low-endemic country.
    Dyrhol-Riise AM; Gran G; Wentzel-Larsen T; Blomberg B; Haanshuus CG; Mørkve O
    BMC Infect Dis; 2010 Mar; 10():57. PubMed ID: 20210999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serial interferon-gamma release assays after rifampicin prophylaxis in a tuberculosis outbreak.
    Lee SH; Lew WJ; Kim HJ; Lee HK; Lee YM; Cho CH; Lee EJ; Lee DY; Ryu SW; Oh SY; Kim SO; Shim TS
    Respir Med; 2010 Mar; 104(3):448-53. PubMed ID: 19879123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. QuantiFERON-TB Gold In-Tube Test for Tuberculosis Prevention in HIV-Infected Patients.
    Khawcharoenporn T; Phetsuksiri B; Rudeeaneksin J; Srisungngam S; Apisarnthanarak A
    Jpn J Infect Dis; 2017 Sep; 70(5):502-506. PubMed ID: 28367883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depressed Gamma Interferon Responses and Treatment Outcomes in Tuberculosis Patients: a Prospective Cohort Study.
    Feng JY; Pan SW; Huang SF; Chen YY; Lin YY; Su WJ
    J Clin Microbiol; 2018 Oct; 56(10):. PubMed ID: 30068533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube Interferon Gamma Release Assays in Patients at Risk for Tuberculosis and in Health Care Workers.
    Theel ES; Hilgart H; Breen-Lyles M; McCoy K; Flury R; Breeher LE; Wilson J; Sia IG; Whitaker JA; Clain J; Aksamit TR; Escalante P
    J Clin Microbiol; 2018 Jul; 56(7):. PubMed ID: 29743310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. QuantiFERON-TB Gold In-Tube Test in the Diagnosis of Latent Tuberculosis Infection in Arthritis Patients Treated with Tumor Necrosis Factor Antagonists.
    Baričević D; Popović Grle S; Morović Vergles J; Čuković Čavka S; Jakopović M; Redžepi G; Boras Z; Baričević M; Samaržija M
    Acta Clin Croat; 2017 Jun; 56(2):203-209. PubMed ID: 29485786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of interferon-gamma response to mitogen in serial QuantiFERON-TB Gold In-Tube assay of routine laboratory practice.
    Woo KS; Choi JL; Kim BR; Kim JE; Kim BG; Lee H; Kim KH
    Clin Chim Acta; 2014 Mar; 430():79-83. PubMed ID: 24389051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Baseline Tuberculin Skin Test and Isoniazid Chemoprophylaxis on Subsequent Quantiferon-TB Gold In-Tube Performance in Young Children Assessed After Tuberculosis Contact in Catalonia.
    Velasco-Arnaiz E; Soriano-Arandes A; Espiau M; Altet N; Fortuny C; Monsonís M; Tebruegge M; Noguera-Julian A
    Pediatr Infect Dis J; 2020 Feb; 39(2):e22-e25. PubMed ID: 31738322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicentre verification study of the QuantiFERON
    Pieterman ED; Liqui Lung FG; Verbon A; Bax HI; Ang CW; Berkhout J; Blaauw G; Brandenburg A; van Burgel ND; Claessen A; van Dijk K; Heron M; Hooghiemstra M; Leussenkamp-Hummelink R; van Lochem E; van Loo IHM; Mulder B; Ott A; Pontesilli O; Reuwer A; Rombouts P; Saegeman V; Scholing M; Vainio S; de Steenwinkel JEM
    Tuberculosis (Edinb); 2018 Jan; 108():136-142. PubMed ID: 29523314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of rituximab therapy on released interferon-γ levels in the QuantiFERON assay among RA patients with different status of Mycobacterium tuberculosis infection.
    Chen YM; Chen HH; Lai KL; Hung WT; Lan JL; Chen DY
    Rheumatology (Oxford); 2013 Apr; 52(4):697-704. PubMed ID: 23264552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in QuantiFERON®-TB Gold In-Tube results during treatment for tuberculous infection.
    Bastos ML; Menzies D; Belo MT; Teixeira EG; de Abreu ST; Antas PR; Trajman A
    Int J Tuberc Lung Dis; 2013 Jul; 17(7):909-16. PubMed ID: 23743310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The evaluation of the utility of QuantiFERON TB-Gold In-Tube; QFT-GIT].
    Matsumoto T; Yamazaki T
    Kekkaku; 2014 Sep; 89(9):743-55. PubMed ID: 25730946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuberculosis treatment effect on T-cell interferon-gamma responses to Mycobacterium tuberculosis-specific antigens.
    Chee CB; KhinMar KW; Gan SH; Barkham TM; Koh CK; Shen L; Wang YT
    Eur Respir J; 2010 Aug; 36(2):355-61. PubMed ID: 19926734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variability of the QuantiFERON®-TB gold in-tube test using automated and manual methods.
    Whitworth WC; Goodwin DJ; Racster L; West KB; Chuke SO; Daniels LJ; Campbell BH; Bohanon J; Jaffar AT; Drane W; Sjoberg PA; Mazurek GH
    PLoS One; 2014; 9(1):e86721. PubMed ID: 24466211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serial QuantiFERON TB-gold in-tube testing during LTBI therapy in candidates for TNFi treatment.
    Bartalesi F; Goletti D; Spinicci M; Cavallo A; Attala L; Mencarini J; Fiori G; Li Gobbi F; Mantella A; Benucci M; Prignano F; Pimpinelli N; Matucci Cerinic M; Girardi E; Bartoloni A
    J Infect; 2013 Apr; 66(4):346-56. PubMed ID: 23103667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relevance of QuantiFERON-TB Gold Plus and Heparin-Binding Hemagglutinin Interferon-γ Release Assays for Monitoring of Pulmonary Tuberculosis Clearance: A Multicentered Study.
    Chedid C; Kokhreidze E; Tukvadze N; Banu S; Uddin MKM; Biswas S; Russomando G; Acosta CCD; Arenas R; Ranaivomanana PP; Razafimahatratra C; Herindrainy P; Rakotonirina J; Raherinandrasana AH; Rakotosamimanana N; Hamze M; Ismail MB; Bayaa R; Berland JL; De Maio F; Delogu G; Endtz H; Ader F; Goletti D; Hoffmann J
    Front Immunol; 2020; 11():616450. PubMed ID: 33603746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. QuantiFERON-TB Gold In-Tube as a Confirmatory Test for Tuberculin Skin Test in Tuberculosis Contact Tracing: A Noninferiority Clinical Trial.
    Muñoz L; Santin M; Alcaide F; Ruíz-Serrano MJ; Gijón P; Bermúdez E; Domínguez-Castellano A; Navarro MD; Ramírez E; Pérez-Escolano E; López-Prieto MD; Gutiérrez-Rodriguez J; Anibarro L; Calviño L; Trigo M; Cifuentes C; García-Gasalla M; Payeras A; Gasch O; Espasa M; Agüero R; Ferrer D; Casas X; González-Cuevas A; García-Zamalloa A; Bikuña E; Lecuona M; Galindo R; Ramírez-Lapausa M; Carrillo R;
    Clin Infect Dis; 2018 Jan; 66(3):396-403. PubMed ID: 29020191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.